Anhui Anke Biotechnology (Group) Co., Ltd. is a pharmaceutical company based in China with a medium risk rating score of 26.2. Specializing in the development, manufacture, and distribution of pharmaceuticals and health-care products, Anhui Anke Biotechnology operates in over 30 provinces in China and exports products internationally. With a focus on sustainability and governance, Anhui Anke Biotechnology is a leader in the ESG industry.